BIOTRONIK announced today the opening of its new Asia Pacific Manufacturing and Research Hub. The 20,000 m² site will serve as the company’s central hub in Asia-Pacific, with hundreds of employees working in manufacturing, quality, research & development (R&D), and sales and marketing. BIOTRONIK, founded in Berlin, Germany, in 1963 is a pioneer in implantable pacemakers, defibrillators, and vascular intervention for 60 years. BIOTRONIK’s presence in Singapore began in 2012, and in 2016, the company inaugurated its first manufacturing site, complementing its high-quality manufacturing sites in Germany, Switzerland and the United States. Now in 2023, the new facility has been designed with an emphasis on workspace agility for modern, optimized collaboration. The new site includes several spacious cleanrooms and laboratories developing and manufacturing state-of-the art Cardiac Rhythm Management (CRM) devices. “We are excited to be the first major manufacturer in the cardiac rhythm mana
Material compliance is concerned with environmental and international laws and regulations that restrict or even prohibit the use of various substances in products.The monitoring of substances of very high concern (SVHC candidates) is regulated by the REACH regulation. We are closely watching the development of the candidate list established according to article 59.If a product contains SVHC candidates of at least 0.1% downstream users must be notified (Article 33 (1)).The following product information sheets depict our current state of knowledge. If there is no product information sheet available, the product does not contain SVHC candidates to the best of our knowledge.
BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and endovascular solutions, proudly announces a multinational distribution partnership with Texray, the pioneering developer of a groundbreaking radiation protection textile. In this collaboration BIOTRONIK will distribute Texray's head and neck protectors starting in selected European and Middle Eastern countries. Both partners aim to raise awareness about the critical importance of radiation protection for healthcare professionals, who serve in environments where radiation exposure is an inherent occupational risk. “Texray's radiation protective textiles complement BIOTRONIK’s product portfolio, enhancing our ability to offer customers comprehensive protection solutions. We are delighted to expand our offering, ensuring that healthcare professionals have a range of radiation protection options to support their safety in their daily work,” says John Brumfield, Global Vice President Marketing CRM at BIOTR
Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.
Coronary drug-eluting stent (DES) systems are stents which are pre-mounted on a balloon catheter. DES are used for the treatment of coronary arteries and release an anti-proliferative drug to the vessel wall.
Our technologies enable physicians to provide highly effective therapies to patients suffering from cardiovascular and endovascular diseases. In the field of electrophysiology, BIOTRONIK offers state-of-the-art solutions that diagnose and treat patients with cardiac arrhythmias.
Coronary resorbable magnesium scaffolds (RMS) are resorbable implants which are pre-mounted on a balloon catheter. RMS are made of magnesium alloys and used for the treatment of coronary arteries and release an anti-proliferative drug to the vessel wall.
Peripheral drug-coated balloons (DCBs) are minimally invasive angioplasty balloons coated in paclitaxel, an anti-proferative drug that is released up dilatation of the balloon within a peripheral artery to treat peripheral artery disease (PAD). Paclitaxel reduces the rate of restenosis and reinterventions, as shown in many clinical trials.
